Supplement marketing is the practice of promoting dietary supplements within FDA and FTC claim rules. Its central problem is trust: the FDA does not approve supplements before they are sold, buyers cannot verify quality themselves, and AI assistants now decide which brands to name. This guide covers the rules, the trust model, the channels, AI visibility data and a compliance checklist.
By the Everything-PR Editorial Team. Updated October 22, 2026.
Supplement marketing is regulated as food-style marketing under the Dietary Supplement Health and Education Act of 1994 (DSHEA), not as drug marketing. According to the FDA, dietary supplements are not approved before they reach consumers, and manufacturers are responsible for the safety and truthfulness of what they sell. The rules that matter most for marketers are about claims.
| Claim type | Example | Rule, according to the FDA |
|---|---|---|
| Structure/function claim | "Supports immune health" | Allowed without FDA pre-approval. The brand must have substantiation, notify the FDA within 30 days of first marketing the claim, and carry the disclaimer that the FDA has not evaluated it. |
| Disease claim | "Treats" or "cures" a condition | Generally not permitted for dietary supplements. |
| Endorsement or influencer post | A paid celebrity post | Must disclose the paid relationship, and the claims in the post must be truthful (FTC guidance). |
Compliance gaps are common. A review of 127 supplements by the HHS Office of Inspector General (report OEI-01-11-00210) found that 7 percent lacked the required disclaimer and 20 percent carried prohibited claims. The FTC also sent more than 70 letters to influencers in early 2017 reminding them to disclose brand relationships, according to a Manatt advertising law summary. The FDA notification, the FTC evidence standard and the 2023 endorsement rules are explained in 5W's supplement marketing claims guide.
Trust is the core because supplements are a credence good, a product whose quality a buyer cannot easily verify even after use. In that kind of market, buyers rely on proxies: third-party testing, clinical research, professional recommendations and a clean regulatory record. Supplement brands that build trust through clinical evidence tend to outperform brands that rely on hype, and the two cases below show the spread.
| Factor | Thorne | Flat Tummy Co |
|---|---|---|
| Source of credibility | Clinical research and practitioner channels | Celebrity and influencer endorsements |
| Key proof point | Mayo Clinic clinical study agreement (announced December 2014) | Kim Kardashian Instagram posts |
| Regulatory record | No comparable action cited here | UK ASA ruling (2018); 2019 Senate letter to the FTC |
| Outcome | $3.8 billion cash deal agreed with P&G, announced August 4, 2026 | Marketing became a case study in influencer risk |
Thorne's trust-first model paid off because credibility was built on evidence a buyer can check. Thorne Research and Mayo Clinic announced in December 2014 that they would run randomized, double-blind, placebo-controlled clinical trials on dietary supplements starting in January 2015. Thorne has since marketed itself on research, practitioner recommendations and quality standards, and P&G's August 4, 2026 announcement describes Thorne as built on science, quality and trust. Thorne's materials emphasize ingredient traceability, clinical backing, testing protocols and practitioner use, and they avoid exaggerated transformation claims. P&G's deal is subject to regulatory approvals and is expected to close later in 2026.
Flat Tummy Co relied on celebrity endorsements and appetite-suppression claims, and regulators and lawmakers scrutinized the result. In 2018 the UK Advertising Standards Authority ruled against a Flat Tummy Tea Instagram post and said the product name itself could be read as a health claim, because the maker could not point to authorised claims supporting the effect. In 2019, Senator Richard Blumenthal asked the FTC to investigate detox teas and cited a Kim Kardashian post for Flat Tummy Co that said the products were "helping me get my tummy back to flat." The pattern is clear: endorsements bought for reach create regulatory exposure when the claims behind them cannot be supported.
Attention is not trust because platforms reward visibility, while consumers judge health products on evidence. Celebrity posts can drive sales quickly, but a post that overstates results invites an advertising ruling, a lawmaker's letter and a skeptical audience. Health products face higher scrutiny than most consumer goods, so a credibility failure is read as an ethical failure, not only a marketing miss.
AI assistants name supplement brands far more often than they cite the brands' own websites. 5WPR's Supplements AI Visibility Index 2026 measured 1,709 AI answers. Thorne appeared in 35.6 percent of them and its owned domain was the cited source in 6.3 percent of answers with retrieval evidence. NOW appeared in 26.3 percent of answers but was cited in only 0.1 percent.
| Brand | Appearance rate | Owned-domain citation rate |
|---|---|---|
| Thorne | 35.6% | 6.3% |
| Garden of Life | 31.4% | 3.3% |
| NOW | 26.3% | 0.1% |
| Nature Made | 23.1% | 4.8% |
| Pure Encapsulations | 19.8% | 0.2% |
| Life Extension | 17.8% | 9.2% |
Third-party publishers supplied most of the evidence, according to the same index: Healthline appeared in 56.1 percent of retrieval-backed answers, Forbes in 35.1 percent, Fortune in 32.6 percent and ConsumerLab in 31 percent. Engines also disagree. In the 5WPR data, Garden of Life appeared in 57.4 percent of ChatGPT's supplement answers but only 9.3 percent of Claude's. The details are in The AI Visibility Citation Gap in Supplement Brands.
Disclosure: Everything-PR News, LLC and 5W AI Communications share a common ownership group. The index above was produced by 5WPR. Everything-PR's editorial team makes its own editorial decisions.
The channels that work are the ones that carry verifiable proof. Practitioner and clinical channels build credibility, as the Thorne and Flat Tummy Co comparison shows, and earned media adds third-party validation, as in the AG1 case. The table summarizes each channel.
| Channel | What it does well | Main risk | Guide |
|---|---|---|---|
| Practitioner and clinical channels | Builds credibility with proof a buyer can check | Slow to build | Trust vs hype |
| Earned media and PR | Third-party validation that AI engines also cite | Claims must be substantiated | AG1 case study |
| Social media campaigns | Reach and community | Disclosure and claim errors | Social media tactics |
| Influencers | Fast awareness | Regulatory and reputational exposure | Trust vs hype |
| Reddit and community forums | Shapes how buyers and AI engines describe a brand | Skeptical communities fact-check claims | Reddit Is Eating Your Supplement Brand Alive |
| AI search visibility | Decides whether a brand is named and cited | Mentions without citations | The AI Citation Gap |
Supplement brands use social media for education, community and trial, and the tactics that last are the ones that carry a verifiable claim and a clear disclosure. The table lists the common formats and the risk each one carries.
| Tactic | How supplement brands use it | Claim and disclosure risk |
|---|---|---|
| Educational series | Posts explaining what an ingredient does, with sources | Claims must stay structure/function |
| Expert Q&A and interviews | Live sessions with nutritionists or clinicians | Experts must disclose paid ties |
| Influencer takeovers and reviews | A creator runs an account for a day or reviews a product | Paid relationships must be disclosed in the post |
| Hashtag and fitness challenges | Users share progress over days or weeks | Transformation claims need substantiation |
| User-generated content contests | Followers submit recipes or routines using the product | Prize and endorsement rules apply |
| Interactive quizzes and polls | Help a buyer choose a product | Recommendations cannot imply disease treatment |
| Behind-the-scenes content | Shows manufacturing and testing steps | Must match the actual testing records |
Before-and-after transformation posts carry the highest risk, because they imply results the brand must be able to support. The disclosure and substantiation rules in the compliance checklist below apply to every tactic in the table.
Generic wellness language costs credibility because words like "clean," "natural" and "science-backed" carry no checkable proof. Replacing them with specific, sourced statements about ingredients, testing and studies is the cheapest credibility upgrade a supplement brand has. The Thorne and Flat Tummy Co comparison shows what that looks like in practice.
The best supplement campaigns pair a clear claim with proof and a consistent voice. EPR's roundup of 25 best supplement and wellness brand marketing campaigns covers the patterns across the category, from podcast-led growth to the Thorne acquisition. For a cautionary example, see Alpha Brain and the possible dangers of health supplements.
Use this checklist before any supplement campaign goes live:
Read the AG1 profile, then browse the Health & Wellness PR guide and the healthcare pillar. For supplement PR programs, see 5W's supplements PR practice.
Supplement marketing is the promotion of dietary supplements through advertising, PR, content and social channels while staying within FDA and FTC rules on claims and endorsements.
No. According to the FDA, dietary supplements are not approved before they reach consumers. Manufacturers are responsible for safety and for the truthfulness of their claims.
A supplement can make structure/function claims, such as supporting a body function, if the brand can substantiate them, notifies the FDA within 30 days and includes the FDA disclaimer, according to FDA guidance. Claims to treat, cure or prevent a disease are generally not permitted.
Supplement brands get cited by publishing plain-language pages on product purpose, ingredients, testing and selection criteria, and by earning coverage on publishers that AI engines already cite, such as Healthline, ConsumerLab and major business outlets.
Influencer marketing carries regulatory and reputational risk for supplements. Posts must disclose paid relationships and cannot make unsupported health claims, as the Flat Tummy Co cases show.
Educational series, expert Q&A sessions, hashtag challenges and user-generated content contests are common formats. Each needs substantiated claims and clear disclosure of paid relationships.
P&G announced on August 4, 2026 an agreement to acquire Thorne for $3.8 billion in cash, saying consumer demand is growing for health products that combine scientific support, quality and practitioner credibility. The deal is subject to regulatory approvals and is expected to close later in 2026.
The UK Advertising Standards Authority ruled in 2018 that a Flat Tummy Tea Instagram post made an unauthorised health claim, and that the product name itself could be construed as one.
A credence good is a product whose quality a buyer cannot easily verify even after use. Supplements fit that definition, so brands rely on certifications, third-party testing and professional endorsement to earn trust.
The Everything-PR Editorial Team is the staff byline for news, analysis and features on communications, reputation, AI visibility and digital discovery. Everything-PR has published since 2009. AI tools assist with research and drafting, and every article is reviewed by a human editor before publication. Coverage follows the Editorial Policy, and substantive corrections are noted on the article under the Corrections Policy.
Kratom and kava marketing rules for 2026: FDA says 7-OH is unlawful in supplements, DEA scheduling is pending, kava has a liver warning. See what to avoid.
Ronaldo Bioniq investment explained: how two footballers backed a supplement startup, how Bioniq uses their names in marketing and what brands can learn.
Billion Dollar Boy Group named a five-member Advisory Board on 21 October 2026 as it forecasts global revenue above $100 million in 2027, after 24% growth.
FDA rules for marketing AI medical devices: how to say cleared vs approved, a claims table for cleared and uncleared tools, and a pre-launch review checklist.
PR salary negotiation for 2027: BLS puts specialist pay at $74,750, from under $44,110 to over $135,150. See where hiring is heading and five steps to ask.
EPR publishes the data every week.
Free. Weekly. Unsubscribe anytime.
